Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan

CompletedOBSERVATIONAL
Enrollment

1,987

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

March 2, 2018

Study Completion Date

March 2, 2018

Conditions
Type II Diabetes Mellitus
Trial Locations (8)

Unknown

Research Site, Changhua

Research Site, Chiayi City

Research Site, Kaohsiung City

Research Site, New Taipei City

Research Site, Taichung

Research Site, Tainan City

Research Site, Taipei

Research Site, Taoyuan District

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY